AOD 9604 (also known as Hexarelin analog) is a modified fragment of the human growth hormone (HGH), specifically the 176-191 segment. This part of the hormone is believed to be responsible for its fat-burning (lipolytic) properties, but without the growth-promoting (and potential blood sugar affecting) effects of the full HGH molecule.
The Theory: How It's Supposed to Work for Weight Loss
The intended mechanism of action is two-fold:
1.Stimulates Fat Breakdown (Lipolysis): It signals fat cells (adipocytes) to break down stored triglycerides into free fatty acids, which can then be used for energy.
2.Inhibits Fat Storage (Lipogenesis): It may also block the body's ability to create and store new fat.
Based on this mechanism, the expected outcome is weight loss, specifically fat loss, not weight gain.
So, Why Would Anyone Think It Causes Weight Gain?
There are a few reasons why someone might associate AOD 9604 with weight gain, though these are typically misunderstandings or related to other factors:
1.Water Retention: While AOD 9604 is designed to avoid this, some individuals might experience minor water retention, which can show as a temporary increase on the scale. This is not fat gain.
2.Increased Appetite: Some users report a slight increase in hunger. If this leads to consuming more calories than are burned, then actual weight gain (from fat or muscle) can occur. The peptide itself isn't causing the gain; the caloric surplus is.
3.Improper Product or Dosing: The market for peptides is not well-regulated. A user could be taking an impure product, a mislabeled product, or an incorrect dose that doesn't provide the intended effect.
4.Combination with Other Therapies: If someone is using AOD 9604 alongside other supplements or medications (e.g., something that causes insulin resistance or increased appetite), the net result could be weight gain despite the AOD.
5.Misattribution: The user might be confusing AOD 9604 with other growth hormone secretagogues (like GHRP-6 or MK-677) which are well-known for significantly increasing appetite and can easily lead to weight gain if diet is not controlled.
The Bottom Line: Evidence and Reality
●Animal Studies: Early studies on obese mice showed promising fat-loss results.
●Human Studies: A large, phase IIb human clinical trial failed to show that AOD 9604 was more effective than a placebo for weight loss over a 12-week period. This is the primary reason it never received FDA approval as a weight-loss drug.
●Anecdotal Evidence: In the bodybuilding and biohacking communities, user reports are mixed. Some swear by its ability to "spot reduce" stubborn fat (like lower belly fat), while others report no noticeable effects.
https://www.hormonerawsource.com/peptides/aod9604-cas-221231-10-3.html
